[Dosing with recombinant human erythropoietin, used for treating early anemia of premature infants].
In 32 premature newborn babies presenting with early anemia of preterm newborn, a human recombinant erythropoietin was used in doses 200 units/kg body mass, 300 units/kg body mass, and 400 units/kg body mass thrice a week for two weeks. A lasting effect has been secured with the dose 400 units/kg body mass three times weekly (i.e. 1200 units/kg body mass), which fact permitted avoiding transfusion of the erythrocytic matter.
Rabbani
Fazal
F
D000740:Anemia / Q000188:drug therapy*; D004334:Drug Administration Schedule; D004921:Erythropoietin / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D007231:Infant, Newborn; D007234:Infant, Premature; D007235:Infant, Premature, Diseases / Q000188:drug therapy*; D011994:Recombinant Proteins
D011994:Recombinant Proteins; D004921:Erythropoietin